HUAKANG BIOMED(08622): Placement agreement terminated
Huakang Biomedical (08622) issued an announcement that due to the conditions of the placement agreement not being met by January 21, 2025...
HUAKANG BIOMED (08622) announced that as the conditions of the subscription agreement were not met by January 21, 2025 (the final deadline related to the subscription matter), the subscription agreement has become invalid and must be stopped and terminated. Any party to the subscription agreement shall not make any claims against the other party regarding the subscription matter, except for any liabilities arising from any previous breaches of the subscription agreement.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


